Tiefenbacher Group about affordable medicines

Why are affordable medicines so important for healthcare?Did you know that affordable (generic) medicines represent the majority of treatments in Europe, accounting for 70% of the treatment volume and 19% of the market value in 2023? They play a crucial role in ensuring patient well-being and public health by providing safe, effective, and affordable treatments. […]
New laboratory and production site for Oncology medicines

Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other diseases?The new complex is located at Tiefenbacher Laboratories in Hyderabad, India, and covers a total area of approximately 4,000 m². It provides laboratories with the latest equipment […]
Tiefenbacher New Market Launch: generic launch Teriflunomide

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]